Assays
Abstract
A device comprising a rigid substrate, a flexible cover element at least partially covering the substrate, a first structure formed in the substrate, adapted for accommodating liquids and adapted for releasing contents of one or more cells, spores, or viruses, the contents including the target molecules, a second structure formed in the substrate, adapted for accommodating liquids and comprising at least one binding member adapted for capturing the target molecules and for determining a value indicative of the presence and/or amount of the target molecules, a micro fluidic network interconnecting at least the first structure and the second structure, and an actuator member adapted for effecting a fluid flow between the first structure and the second structure by pressing the flexible cover element against the substrate to selectively close a portion of the micro fluidic network.
Claims
exact text as granted — not AI-modified1 - 256 . (canceled)
257 . A method for detecting a human immunodeficiency virus (HIV) target nucleic acid in a liquid, comprising:
a) introducing a liquid into a reaction chamber of a microfluidic device, the liquid comprising an HIV polynucleotide, binding the HIV polynucleotide to a first binding member located within the reaction chamber; b) amplifying the HIV polynucleotide within the reaction chamber to form amplicons, the amplification being performed in the presence of a reporter compound, binding a subset of the reporter compound to amplicons within the reaction chamber, binding a remaining subset of the reporter compound to a second binding member within the reaction chamber, and detecting the remaining subset of the reporter compound bound to the second binding member; and c) determining a value indicative of the presence and/or amount of reporter compound captured on the second binding member; and determining a value indicative of the amount of target nucleic acid based on the value indicative of the amount of reporter compound captured on the second binding member.
258 . The method of claim 257 , wherein said HIV polynucleotide is HIV RNA.
259 . The method of claim 258 , wherein said amplifying is RT-PCR.
260 . The method of claim 257 , wherein said HIV polynucleotide is HIV DNA.
261 . The method of claim 257 , wherein said HIV polynucleotide is free or cell-associated.
262 . The method of claim 257 , wherein said first binding member and said second binding members are solid supports.
263 . The method of claim 262 , wherein said first binding members is a latex bead or a magnetic bead.
264 . The method of claim 262 , wherein said second binding member is an array surface.
265 . The method of claim 264 , wherein the array surface comprises one or more different reporter specific capture molecules being capable of capturing a reporter compound on the second binding member.
266 . The method of claim 257 , wherein said reporter compound is an oligonucleotide.
267 . The method of claim 266 , wherein said oligonucleotide is labeled.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.